According to Rhythm Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 310. At the end of 2024 the company had a P/S ratio of 27.9.
P/S ratio history for Rhythm Pharmaceuticals from 2017 to 2024